Compounds > xaliproden
Page last updated: 2024-09-03

xaliproden and Acute Confusional Senile Dementia

xaliproden has been researched along with Acute Confusional Senile Dementia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Douillet, P; Orgogozo, JM1
Fessler, B1
Confort-Gouny, S; Cozzone, PJ; Fournier, J; Keane, P; Le Fur, Y; Lemaire, L; Ponthus, C; Vion-Dury, J1

Other Studies

3 other study(ies) available for xaliproden and Acute Confusional Senile Dementia

ArticleYear
What we have learned from the Xaliproden Sanofi-aventis trials.
    The journal of nutrition, health & aging, 2009, Volume: 13, Issue:4

    Topics: Alzheimer Disease; Biomarkers; Humans; Magnetic Resonance Imaging; Naphthalenes; Pyridines; Randomized Controlled Trials as Topic; Research Design

2009
[Alzheimer's disease: irreparable damage in the brain?].
    Medizinische Monatsschrift fur Pharmazeuten, 1993, Volume: 16, Issue:11

    Topics: Aged; Alzheimer Disease; Brain Damage, Chronic; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Naphthalenes; Parasympathomimetics; Pyridines

1993
Magnetic resonance imaging of the neuroprotective effect of xaliproden in rats.
    Investigative radiology, 2002, Volume: 37, Issue:6

    Topics: Alzheimer Disease; Animals; Brain; Choline O-Acetyltransferase; Disease Models, Animal; Enzyme Inhibitors; Magnetic Resonance Imaging; Male; Naphthalenes; Neuroprotective Agents; Pyridines; Rats; Rats, Sprague-Dawley; Time Factors; Vincristine

2002